Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US House Co-signs Banking For Hemp Industry

Using Cannabinoids In Supplements Remains Unlawful Under FDA Regulations

Apr 20 2021

• By Malcolm Spicer

Related Content

CBD Supplement Firms Can Lawfully Use Banks In Legislation House Passed

Sep 27 2019

'Historic' Cannabis Legislation Passed By House Would Lift US Cannabinoids Business Roadblocks

Dec 18 2020

UK CBD Limbo Continues – Full List Of ‘Legal’ Products Delayed Until June

Apr 20 2021

Legislating Hemp As Dietary Ingredient: Wrapping US Market In A Bow, Or Tying DSHEA In Knots?

Mar 09 2021

Additional Topics

International United States Cannabidiol CBD Dietary Supplements Legislation Advertising, Marketing & Sales Commercial Compliance Distribution FDA Ingredients Policy Politics Regulation Consumer

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window